Killer dendritic cells and their potential for cancer immunotherapy Nicolas LarmonierJennifer FraszczakEmmanuel Katsanis Review 18 July 2009 Pages: 1 - 11
Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity Cristina GarridoIgnacio AlgarraAngel M. Garcia-Lora Original Article 09 May 2009 Pages: 13 - 26
Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome Franco Maria VenanziMassimiliano PetriniAngela Riccobon Original Article 07 May 2009 Pages: 27 - 34
The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells Evelien L. J. M. SmitsNathalie CoolsViggo F. I. Van Tendeloo Original Article 16 May 2009 Pages: 35 - 46
Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice Fuminori AbeAlicia J. DaffernerJames E. Talmadge Original Article 18 May 2009 Pages: 47 - 62
New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy Vittore CeredaDiane J. PooleKwong Y. Tsang Original Article 04 June 2009 Pages: 63 - 71
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors Miroslaw J. SzczepanskiMarta SzajnikMichael Boyiadzis Original Article 13 June 2009 Pages: 73 - 79
Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma Alvaro LladserKarl LjungbergRolf Kiessling Original Article 14 June 2009 Pages: 81 - 92
Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth Pei-he LiangKe-qin ZhangFeng-shuo Jin Original Article 19 June 2009 Pages: 93 - 101
Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells Jacobus J. BoschUzoma K. IheagwaraSuzanne Ostrand-Rosenberg Original Article 26 June 2009 Pages: 103 - 112
Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide Ronald C. HendricksonVito R. CicinnatiAlbert B. DeLeo Original Article 27 June 2009 Pages: 113 - 124
Expression of CD13/aminopeptidase N in precursor B-cell leukemia: role in growth regulation of B cells Ankit SaxenaAmbak RaiDipendra Kumar Mitra Original Article 28 June 2009 Pages: 125 - 135
Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination Vedran RadojcicKarl B. BezakLeo Luznik Original Article 10 July 2009 Pages: 137 - 148
Calicum microdomains form within neutrophils at the neutrophil–tumor cell synapse: role in antibody-dependent target cell apoptosis Andrea J. ClarkMichelle DiamondHoward R. Petty Original Article 11 July 2009 Pages: 149 - 159
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen Lavakumar KaryampudiChristopher J. KrcoKeith L. Knutson Original Article 21 July 2009 Pages: 161 - 171
Comparative proteomical and metalloproteomical analyses of human plasma from patients with laryngeal cancer Clarissa P. C. GomesMirna S. FreireOctávio Luiz Franco Original Article 23 July 2009 Pages: 173 - 181